Skip to main content
Premium Trial:

Request an Annual Quote

Tekmira to List Shares on Nasdaq

Premium

Tekmira Pharmaceuticals this week announced that it plans to file to list its shares on the Nasdaq Stock Market.

Currently, the British Columbia-based company's stock is traded on the Toronto Stock Exchange.

"We anticipate that listing our common shares on Nasdaq will broaden Tekmira's exposure to leading North American healthcare investors," Tekmira President and CEO Mark Murray said in a statement. "Many of our peers have securities listed in the United States and we believe doing so is a logical step in the evolution of Tekmira to be appropriately valued."

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.